These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Design and synthesis of potent and multifunctional aldose reductase inhibitors based on quinoxalinones. Qin X, Hao X, Han H, Zhu S, Yang Y, Wu B, Hussain S, Parveen S, Jing C, Ma B, Zhu C. J Med Chem; 2015 Feb 12; 58(3):1254-67. PubMed ID: 25602762 [Abstract] [Full Text] [Related]
34. Synthesis and Aldose Reductase Inhibitory Activity of Botryllazine A Derivatives. Saito R, Ishibashi K, Noumi M, Uno S, Higashi S, Goto M, Kuwahara S, Komatsu T. Chem Pharm Bull (Tokyo); 2019 Dec 29; 67(6):556-565. PubMed ID: 31155561 [Abstract] [Full Text] [Related]
35. The inhibitory effect of Isoflavones isolated from Caesalpinia pulcherrima on aldose reductase in STZ induced diabetic rats. Kumar MP, Sankeshi V, Naik RR, Thirupathi P, Das B, Raju TN. Chem Biol Interact; 2015 Jul 25; 237():18-24. PubMed ID: 25986969 [Abstract] [Full Text] [Related]
36. Effects of a novel potent aldose reductase inhibitor, GP-1447, on aldose reductase activity in vitro and on diabetic neuropathy and cataract formation in rats. Ashizawa N, Yoshida M, Sugiyama Y, Akaike N, Ohbayashi S, Aotsuka T, Abe N, Fukushima K, Matsuura A. Jpn J Pharmacol; 1997 Feb 25; 73(2):133-44. PubMed ID: 9074947 [Abstract] [Full Text] [Related]
37. Screening and characterization of aldose reductase inhibitors from Traditional Chinese medicine based on ultrafiltration-liquid chromatography mass spectrometry and in silico molecular docking. Zhang H, Xu C, Tian Q, Zhang Y, Zhang G, Guan Y, Tong S, Yan J. J Ethnopharmacol; 2021 Jan 10; 264():113282. PubMed ID: 32890716 [Abstract] [Full Text] [Related]